Elevance Health Inc (NYSE: ELV) has recently experienced extremely meaningful negative changes in investment behavior: the stock’s recent price decline challenged its longer term uptrend, its shorter term price trend turned down, and negative upside/downside volume developed.
Elevance Health Inc (NYSE: ELV) has recently experienced minimal negative changes in fundamentals: significant quarterly sales deceleration occurred.
In light of these highly negative signals we are reviewing our current Overall Rating of C. We would view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, ELV is expected to continue to be a major Value Builder.
Elevance Health has a current Value Trend Rating of C (High Neutral). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Elevance Health has a neutral Appreciation Score of 48 and a slightly positive Power Rating of 69, with the High Neutral Value Trend Rating the result.
Recent Price Action
On 7/19/24, Elevance Health Inc (NYSE: ELV) stock declined slightly by -0.9%, closing at $500.12. This decline was accompanied by normal trading volume. The stock has declined -6.3% during the last week but has been strong relative to the market over the last nine months.
Be the first to comment